Skip to main content

Together we are beating cancer

Donate now

Womb (uterine or endometrial) cancer

Showing 12 out of 33 results
Endometrial adenocarcinoma cells viewed under the microscope

Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer

by Jacob Smith | News | 8 March 2024

8 March 2024

A person stepping onto a set of scales

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine. Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

by Jacob Smith | News | 19 April 2022

19 April 2022

Woman

Our new stats show a staggering variation in treatment plans for women diagnosed with womb cancer across England. Our new stats show a staggering variation in treatment plans for women diagnosed with womb cancer across England.

by Gabriella Beer | Analysis | 11 October 2019

11 October 2019

Rising levels of obesity among UK women have helped fuel a 54 per cent increase in womb cancer rates over the last two decades, according to new statistics. Rising levels of obesity among UK women have helped fuel a 54 per cent increase in womb cancer rates over the last two decades, according to new statistics.

by Cancer Research UK | News | 13 April 2016

13 April 2016

In the third in our series of guest posts from our Cancer Campaigns Ambassadors, Rosa shares her personal story about surgery. In the third in our series of guest posts from our Cancer Campaigns Ambassadors, Rosa shares her personal story about surgery.

by Nick Peel | Analysis | 2 February 2015

2 February 2015